The Adaptive Cycle of Synthetic Opioids

The white paper explains how synthetic opioids continue to evolve faster than public safety systems can detect them, with a new class—orphines—now emerging after fentanyls and nitazenes. These benzimidazol‑2‑one opioids, including compounds like cychlorphine, can be extremely potent, appear in complex drug mixtures, and often evade routine toxicology and field screening, creating a dangerous gap between real‑world exposure and official data. A Tennessee case example shows how newly engineered opioids can drive fatal overdoses before they are visible in dashboards or fully understood by labs and policymakers. The paper argues that frontline teams need resilient preparedness, rapid field intelligence tools such as the MX908, and expert reachback support to shorten the time between encountering an unknown substance and achieving operational clarity.